Amesite (AMST) EBITDA (2019 - 2025)

Amesite (AMST) has disclosed EBITDA for 7 consecutive years, with -$745253.0 as the latest value for Q4 2025.

  • Quarterly EBITDA rose 34.1% to -$745253.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Dec 2025, up 37.6% year-over-year, with the annual reading at -$3.6 million for FY2025, 21.31% up from the prior year.
  • EBITDA hit -$745253.0 in Q4 2025 for Amesite, down from -$662124.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$662124.0 in Q3 2025 to a low of -$3.2 million in Q1 2021.
  • Historically, EBITDA has averaged -$1.5 million across 5 years, with a median of -$1.1 million in 2024.
  • Biggest five-year swings in EBITDA: plummeted 198.23% in 2021 and later skyrocketed 69.41% in 2022.
  • Year by year, EBITDA stood at -$2.3 million in 2021, then surged by 69.41% to -$711992.0 in 2022, then plummeted by 34.28% to -$956084.0 in 2023, then fell by 18.28% to -$1.1 million in 2024, then soared by 34.1% to -$745253.0 in 2025.
  • Business Quant data shows EBITDA for AMST at -$745253.0 in Q4 2025, -$662124.0 in Q3 2025, and -$857678.0 in Q2 2025.